How did KMDA's recent EPS compare to expectations?
The most recent EPS for Kamada Ltd is $0.06, not beating expectations of $0.07.
How did Kamada Ltd KMDA's revenue perform in the last quarter?
Kamada Ltd revenue for the last quarter is $0.06
What is the revenue estimate for Kamada Ltd?
According to 6 of Wall street analyst, the revenue estimate of Kamada Ltd range from $49.87M to $43.02M
What's the earning quality score for Kamada Ltd?
Kamada Ltd has a earning quality score of B+/57.95986. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Kamada Ltd report earnings?
Kamada Ltd next earnings report is expected in 2026-06-09
What are Kamada Ltd's expected earnings?
Kamada Ltd expected earnings is $46.32M, according to wall-street analysts.
Did Kamada Ltd beat earnings expectations?
Kamada Ltd recent earnings of $44.67M does not beat expectations.
Key Stats
Prev.Close
$8.2
Open
$8.14
Day's Range
$8.1 - $8.28
52 week range
$5.54 - $9.35
Volume
71.6K
Avg.Volume
74.8K
Dividend yield
--
EPS (TTM)
0.35
Market Cap
$474.1M
What is KMDA?
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.